The umbilical cord blood stem cell preservation company, Cord Blood America, announces a new campaign to engage the attention and interest of clients, investors and the general public through the new platform of social networking technology.
The California based biotechnology company ISCO receives the first $1 million tranche of private equity funding.
Anthrogenesis Corporation, a division of Celgene, is awarded yet another U.S. patent for inventions related to methods of deriving adult stem cells from human placentas.
A U.S. doctor has been invited to visit China as part of a fact-finding mission on the current state of stem cell therapies that are only available outside of the United States.
The stem cell company Neuralstem has filed an application with the FDA to begin the first clinical trials ever to be conducted with adult stem cells in the treatment of amyotrophic lateral sclerosis.
The U.S. Food and Drug Administration has granted marketing approval for Mozobil, Genzyme’s patented drug which stimulates the mobilization of autologous adult stem cells, now available for the treatment of non-Hodgkin’s lymphoma and multiple myeloma.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.